Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 14
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Cogent Biosciences Inc
COGT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$28.15
0.06
0.21%
Ult. Agg.: Oct 14, 4:53 PM
$28.47
0.38
1.35%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Cogent Biosciences Financials
Cogent Biosciences (COGT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Cogent Biosciences Q2 EPS $(0.52) Beats $(0.57) Estimate
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 1.89 percent increase over losses of $(0.53) per share from
Benzinga Newsdesk
PRO
Cogent Biosciences Q1 EPS $(0.53) Beats $(0.56) Estimate
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 1.92 percent decrease over losses of $(0.52) per share from
Benzinga Newsdesk
PRO
Cogent Biosciences Q4 EPS $(0.61) Misses $(0.53) Estimate
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.53) by 15.97 percent. This is a 577.78 percent decrease over losses of $(0.09) per share
Benzinga Newsdesk
Gold Jumps Over 2%; Dole Shares Gain After Q3 Results
Avi Kapoor
S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings
Avi Kapoor
PRO
Cogent Biosciences Q2 EPS $(0.53) Beats $(0.58) Estimate
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.58) by 9.4 percent. This is a 10.17 percent increase over losses of $(0.59) per share from
Benzinga Newsdesk
